glp 1 agonist What You Should Know Before Asking for a GLP-1 Prescription GLP-1 Receptor Agonist Market Growth

Albiglutide: The HARMONY Outcomes trial (2018) reported a 22% MACE reduction (HR 0.78, 95% CI 0.680.90) in 9463 T2DM patients, driven by reduced MI [18]

18,24 The efficacy and safety of injectable semaglutide was explored in the SUSTAIN trials program

Available as a weekly subcutaneous injection for diabetes (Ozempic) or weight management (Wegovy), and as a daily oral tablet (Rybelsus) for diabetes only, semaglutide has demonstrated substantial weight loss and metabolic improvements in clinical trials

2024 Jan;23(1):37-45

Circulating Levels of Soluble Dipeptidyl Peptidase-4 Are Dissociated from Inflammation and Induced by Enzymatic DPP4 Inhibition

Many medications can be taken alongside GLP-1 therapy, but interactions exist